Wearable Injectors Market Share

  • Report ID: 3300
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Wearable Injectors Market Share

Geographically, the wearable injectors market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. The market in the Asia Pacific is likely to dominate majority revenue share by 2036, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region. Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue over the forecast period, ascribing to the strong presence of leading market players in the region. Along with this, North America also leads in terms of presence of strong healthcare infrastructure, which is also expected to contribute to the market growth in the region. Alternatively, the market in Europe is also anticipated to occupy a significant share in the market on account of its success in drug trials, rising cases of cancer and the increasing ageing population in the region. As per the Annals of Oncology of the European Society for Medical Oncology, the predictions for cancer-related deaths in the European Union for 2021 are 1,267,000 deaths

Research Nester
Wearable-Injectors-Market-Share
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3300
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of wearable injectors is evaluated at USD 9.36 billion.

Wearable Injectors Market size was valued at USD 8.63 billion in 2023 and is set to cross USD 31.98 billion by 2036, expanding at more than 10.6% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of chronic medical conditions and the technological developments in drug delivery injectors globally will fuel the market growth.

Asia Pacific is likely to dominate majority revenue share by 2036, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region.

The major players in the market include Amgen Inc., Insulet Corporation, YPSOMED AG, among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample